Binge-eating Disorder Treatment Market Research Report 2024

DUBLIN, Feb. 22, 2024 /PRNewswire/ -- The "Binge-eating Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to  ResearchAndMarkets.com's offering.

The report evaluates key market dynamics, shedding light on factors propelling the market trajectory toward a projected valuation of USD 859.26 million by 2028, with a Compound Annual Growth Rate (CAGR) of 7.25%.

As society becomes increasingly aware of the complexities surrounding BED, an uptick in the diagnosis and the urgent need for effective interventions have ensued. Market growth is particularly driven by rising cases of BED and amplified by greater awareness around mental health disorders.

Antidepressant Medications Lead the Charge in Treatment Type Segmentation

In a critical examination of treatment type effectiveness, antidepressant medications are highlighted as the frontrunners in the market. They play a pivotal role in modulating mood-related neurotransmitters, potentially curbing the compulsion to binge-eat, thereby enhancing patient outcomes.

Offline Distribution Channels Maintain a Stronghold

With in-person healthcare interactions at its core, the offline distribution channel remains a significant contributor to market growth. This traditional treatment avenue secures the privacy and individual attention that patients with BED often require.

Key Regional Surges and Trends

The concentration in North America—mostly the United States and Canada—commands a substantial market presence, reflective of the high prevalence of BED in these regions.

Industry Advancements and Technological Integration Transform Treatment Accessibility

The seamless integration of technology in healthcare, through tools such as telemedicine and digital therapeutics, promulgates new opportunities for managing BED. These advancements streamline the diagnosis process and enable remote treatment, a crucial factor during unprecedented times as the global population navigates new normals in healthcare provision.

The report presents a detailed analysis of the current market scenario, touching on crucial areas such as the transformative impact of cognitive-behavioral therapy (CBT) on BED, the burgeoning role of online support networks, and the potentials unlocked by the gradual destigmatization of eating disorders.

This granular market assessment examines segment-specific growth, various therapy approaches, and promising regional markets. It is an essential read for healthcare providers, investors, pharmaceutical companies, and stakeholders seeking a comprehensive understanding of the Binge-eating Disorder Treatment Market and the opportunities it presents.

The diversified landscape of this market is underscored by numerous players working towards innovative treatment solutions. With patient-centric approaches and the adherence to stringent research methodologies, the report ensures that readers are well-informed of the intricacies and nuances that characterize the Binge-eating Disorder Treatment Market.

A selection of companies mentioned in this report includes

• Viatris Inc.
• Johnson and Johnson
• Lupin Ltd.
• Omeros Corp.
• Pyramid Healthcare Inc.
• Sumitomo Pharma Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Eli Lilly and Co
• Tonix Pharmaceuticals Holding Corp.
• Tryp Therapeutics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/mpei25

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets